Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors.
- Omobolaji Oyekunle Akala
- , Ronak Shah
- , Brian R. Untch
- , Virginia Kelly
- , Joanne F. Chou
- , Marc Ladanyi
- , Michael F. Berger
- , David S. Klimstra
- , Diane Lauren Reidy
- , Nitya Prabhakar Raj
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.